DE3485965T2 - Monoklonaler antikoerper mit spezifitaet gegen nur einen typ eines isozyms der schweren kette des menschlichen herzmyosins. - Google Patents

Monoklonaler antikoerper mit spezifitaet gegen nur einen typ eines isozyms der schweren kette des menschlichen herzmyosins.

Info

Publication number
DE3485965T2
DE3485965T2 DE8484107663T DE3485965T DE3485965T2 DE 3485965 T2 DE3485965 T2 DE 3485965T2 DE 8484107663 T DE8484107663 T DE 8484107663T DE 3485965 T DE3485965 T DE 3485965T DE 3485965 T2 DE3485965 T2 DE 3485965T2
Authority
DE
Germany
Prior art keywords
antibody
type
heavy chain
myosin
muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8484107663T
Other languages
German (de)
English (en)
Other versions
DE3485965D1 (de
Inventor
Masahito Sugi
Yoshio Yazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Publication of DE3485965D1 publication Critical patent/DE3485965D1/de
Application granted granted Critical
Publication of DE3485965T2 publication Critical patent/DE3485965T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1075—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an enzyme
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8484107663T 1983-07-06 1984-07-02 Monoklonaler antikoerper mit spezifitaet gegen nur einen typ eines isozyms der schweren kette des menschlichen herzmyosins. Expired - Fee Related DE3485965T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58122579A JPS6028998A (ja) 1983-07-06 1983-07-06 心筋ミオシン重鎖に対する単一クロ−ン抗体

Publications (2)

Publication Number Publication Date
DE3485965D1 DE3485965D1 (de) 1992-12-03
DE3485965T2 true DE3485965T2 (de) 1993-03-18

Family

ID=14839400

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484107663T Expired - Fee Related DE3485965T2 (de) 1983-07-06 1984-07-02 Monoklonaler antikoerper mit spezifitaet gegen nur einen typ eines isozyms der schweren kette des menschlichen herzmyosins.

Country Status (7)

Country Link
US (1) US4767843A (https=)
EP (1) EP0131834B1 (https=)
JP (1) JPS6028998A (https=)
KR (1) KR910008637B1 (https=)
AU (1) AU570696B2 (https=)
CA (1) CA1225608A (https=)
DE (1) DE3485965T2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60201260A (ja) * 1984-03-27 1985-10-11 Yamasa Shoyu Co Ltd 心疾患診断薬
JPH0625762B2 (ja) * 1985-06-13 1994-04-06 ヤマサ醤油株式会社 ミオシン軽鎖の測定法
GB2200358B (en) * 1987-01-27 1991-02-27 Univ Birmingham Materials for in vivo detection of cardiac damage, and methods for their preparation
US5046499A (en) * 1988-06-13 1991-09-10 Centocor, Inc. Method for myocardial infarct risk assessment
CA2050941C (en) * 1989-03-28 1999-02-23 Ryozo Nagai Antibody to smooth muscle myosin heavy chains
US5830720A (en) * 1989-04-21 1998-11-03 Boehringer Mannheim Gmbh Recombinant DNA and expression vector for the repressible and inducible expression of foreign genes
US5364612A (en) * 1991-05-06 1994-11-15 Immunomedics, Inc. Detection of cardiovascular lesions
AU691675B2 (en) * 1994-10-25 1998-05-21 Yamasa Corporation Antibody reagent for detecting dissecting aortic aneurysm and use thereof
WO1997029784A1 (en) * 1996-02-19 1997-08-21 Yamasa Corporation Diagnostic agent for angiopathic diseases
US6248869B1 (en) 1997-05-29 2001-06-19 Medical Analysis Systems, Inc. Troponin I forms and use of the same

Also Published As

Publication number Publication date
EP0131834B1 (en) 1992-10-28
JPH0231958B2 (https=) 1990-07-17
JPS6028998A (ja) 1985-02-14
CA1225608A (en) 1987-08-18
US4767843A (en) 1988-08-30
EP0131834A2 (en) 1985-01-23
KR850001282A (ko) 1985-03-18
AU570696B2 (en) 1988-03-24
AU3022884A (en) 1985-01-10
EP0131834A3 (en) 1987-06-24
DE3485965D1 (de) 1992-12-03
KR910008637B1 (ko) 1991-10-19

Similar Documents

Publication Publication Date Title
DE3888224T2 (de) Bestimmung vom Tumornekrosefaktor; monoklonaler Antikörper und Zusammensetzung.
DE69432629T3 (de) Antikörper gegen beta-amyloid oder derivative davon und seine verwendung
DE3887675T2 (de) Antikörper.
DE3587507T2 (de) Monoklonale antikörper gegen alveolares oberflächenaktives protein.
DE68912403T2 (de) Monoklonaler Antikörper, spezifisch für eine in transformierten Zellen exprimierte Fibronectin-Sequenz, Hybridoma, das diesen Antikörper erzeugt und Verwendung dieses monoklonalen Antikörpers zur Diagnose von Tumoren.
DE3631229A1 (de) Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung
DE3785038T2 (de) Monoklonale antikoerper gegen nicht reduzierte, nicht enzymatisch glykolysierte proteine.
DE3485965T2 (de) Monoklonaler antikoerper mit spezifitaet gegen nur einen typ eines isozyms der schweren kette des menschlichen herzmyosins.
DE3751182T2 (de) Monoklonale Antikörper, B-spezifisch für Apolipoprotein, die von zwei Hybridomen erzeugt werden.
DE60128452T2 (de) Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung
DE68921374T2 (de) Monoklonaler Antikörper gegen menschliche Mangan-Superoxiddismutase, Verfahren zu dessen Herstellung, Testreagens, Kit und Testmethode unter Verwendung desselben, Verfahren zur Diagnose von menschlichem Eierstockkrebs und von Herzinfarkt.
DE69112225T2 (de) Immunodiagnostische probe für gelenkrheumatismus.
DE3686766T2 (de) Monoklonaler antikoerper gegen glutathion s-transferase und dessen verwendung zur diagnose von krebs.
DE69026875T2 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
DE3780256T2 (de) Anti-pci-monoklonaler antikoerper.
DE3850993T2 (de) Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2.
DE3686599T2 (de) Verfahren zur bestimmung der leichten kette von myosin.
DE3852236T2 (de) Verfahren zur Kontrolle der Leukozyten-Extravasation.
DE3887727T2 (de) Partikelstabilisierte Epitope zur Standardisierung und Kontrolle von Immuntests.
DE68911713T2 (de) Monoklonale Antikörper, die atriales natriuretisches Polypeptide erkennen, ihre Herstellung und Verwendung.
DE3885975T2 (de) Monoklonale Antikörper gegen menschliche alpha-Atrialnatriüretic-Polypeptide und entsprechende Hybridome, deren Herstellung und Verwendung.
EP0195331A2 (de) Monoklonale Antikörper gegen atriale, natriurethische Peptide
DE3785795T2 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
DE68914345T2 (de) Gamma-atriales, natriuretisches Polypeptid erkennende monoklonale Antikörper, solche Antikörper produzierende Hybridome und deren Herstellung und Verwendung.
EP0289930B1 (de) Monoklonaler Antikörper zur selektiven immunologischen Bestimmung von intaktem Prokollagen Peptid (Typ III) und Prokollagen (Typ III) in Körperflüssigkeiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee